|
Real-time Estimate
Cboe Europe
09:11:01 09/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 14,076.00 GBX | +1.05% |
|
+1.63% | +2.15% |
| 05:38pm | AstraZeneca PLC : Deutsche Bank remains Neutral | ZD |
| 02:31pm | Berenberg raises Autotrader and likes Rightmove | AN |
Company Valuation: AstraZeneca PLC
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,82,034 | 2,09,442 | 2,09,268 | 2,03,171 | 2,87,813 | 2,88,751 | - | - |
| Change | - | 15.06% | -0.08% | -2.91% | 41.66% | 0.33% | - | - |
| Enterprise Value (EV) 1 | 2,06,417 | 2,32,365 | 2,31,778 | 2,27,741 | 3,11,187 | 3,09,296 | 3,02,194 | 2,93,257 |
| Change | - | 12.57% | -0.25% | -1.74% | 36.64% | -0.61% | -2.3% | -2.96% |
| P/E | 1,469x | 64.1x | 35.4x | 29.1x | 28.4x | 24.4x | 20.9x | 18.5x |
| PBR | 4.24x | 5.65x | 5.39x | 5.02x | 5.96x | 5.36x | 4.64x | 3.99x |
| PEG | - | 0x | 0.4x | 1.6x | 0.6x | 1.4x | 1.2x | 1.5x |
| Capitalization / Revenue | 4.87x | 4.72x | 4.57x | 3.76x | 4.9x | 4.56x | 4.28x | 4.04x |
| EV / Revenue | 5.52x | 5.24x | 5.06x | 4.21x | 5.3x | 4.88x | 4.48x | 4.1x |
| EV / EBITDA | 27.2x | 25.2x | 17.1x | 13.6x | 16x | 13.7x | 12.4x | 10.9x |
| EV / EBIT | 20.8x | 17.4x | 15.9x | 13.5x | 16.8x | 14.5x | 13x | 11.5x |
| EV / FCF | 42.4x | 26.7x | 25.8x | 22.9x | 26.5x | 33.9x | 24.1x | 20x |
| FCF Yield | 2.36% | 3.75% | 3.88% | 4.36% | 3.78% | 2.95% | 4.16% | 5% |
| Dividend per Share 2 | 2.87 | 2.9 | 2.9 | 3.1 | 3.2 | 3.326 | 3.544 | 3.659 |
| Rate of return | 2.44% | 2.15% | 2.15% | 2.37% | 1.72% | 1.79% | 1.9% | 1.97% |
| EPS 2 | 0.08 | 2.11 | 3.81 | 4.5 | 6.54 | 7.644 | 8.927 | 10.06 |
| Distribution rate | 3,588% | 137% | 76.1% | 68.9% | 48.9% | 43.5% | 39.7% | 36.4% |
| Net sales 1 | 37,417 | 44,351 | 45,811 | 54,073 | 58,739 | 63,358 | 67,394 | 71,481 |
| EBITDA 1 | 7,586 | 9,237 | 13,580 | 16,691 | 19,476 | 22,529 | 24,441 | 26,993 |
| EBIT 1 | 9,928 | 13,350 | 14,534 | 16,928 | 18,478 | 21,258 | 23,264 | 25,559 |
| Net income 1 | 112 | 3,288 | 5,961 | 7,035 | 10,225 | 11,693 | 13,579 | 15,294 |
| Net Debt 1 | 24,383 | 22,923 | 22,510 | 24,570 | 23,374 | 20,546 | 13,443 | 4,506 |
| Reference price 2 | 117.51 | 135.16 | 135.02 | 131.05 | 185.60 | 186.17 | 186.17 | 186.17 |
| Nbr of stocks (in thousands) | 15,49,159 | 15,49,528 | 15,49,926 | 15,50,317 | 15,50,726 | 15,51,024 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 06/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 24.46x | 4.89x | 13.77x | 1.79% | 29TCr | |
| 39.62x | 13.42x | 28.51x | 0.5% | 1,20600Cr | |
| 40.43x | 6.79x | 19.09x | 1.93% | 66TCr | |
| 37.52x | 8.51x | 17.57x | 2.38% | 51TCr | |
| 20.98x | 5.12x | 12.74x | 2.57% | 38TCr | |
| 104.15x | 5.94x | 25.33x | 2.32% | 36TCr | |
| 23.47x | 5.94x | 14.26x | 2.69% | 31TCr | |
| 23.75x | 7.3x | 13.55x | 2.19% | 25TCr | |
| -39.18x | 7.27x | 45.77x | 1.98% | 21TCr | |
| 11.68x | 4.22x | 8.53x | 4.2% | 18TCr | |
| Average | 28.69x | 6.94x | 19.91x | 2.25% | 43.57TCr | |
| Weighted average by Cap. | 35.30x | 8.37x | 21.31x | 1.83% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AZN Stock
- Valuation AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
